Sutro Biopharma, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Sutro Biopharma, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Sutro Biopharma, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Sutro Biopharma, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
34 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Sutro Biopharma, Inc. (Sutro), formerly Fundamental Applied Biology, Inc. is a biopharmaceutical company that focuses on the development therapeutics for the treatment of cancer. The companys pipeline product portfolio includes antibody drug conjugate therapeutics, multi-specific antibody-based therapeutics, biochemical synthesis systems, non-natural amino acids and protein drug candidates. Sutros Xpress cell-free expression (CF) and Xpress CF+ technology provides a platform for the discovery and development of antibodies. The company works in collaboration with the pharmaceutical and biotechnology companies to discover and develop the novel protein therapeutics.

Sutro Biopharma, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

  
Source:
Document ID
GDPH193114D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Sutro Biopharma, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Sutro Biopharma, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Sutro Biopharma, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Sutro Biopharma, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Sutro Biopharma, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201692
Sutro Biopharma, Inc., Pharmaceuticals &Healthcare, Deal Details1120
  Venture Financing111
    SutroVax Raises Funds Through Initial Financing Round111
    Sutro Biopharma Raises US$26 Million In Series D Financing122
    Sutro Biopharma Raises US$16.5 Million In Second Tranche Of Series C Financing142
    Sutro Biopharma Raises US$20 Million In First Tranche Of Series C Financing162
  Partnerships181
    Sutro Enters into Co-Development Agreement with Celgene182
    Sutro Biopharma Enters into Agreement with University of California, San Francisco201
    Sutro Biopharma Enters Into Co-Development Agreement With Memorial Sloan-Kettering Cancer Center212
    Sutro Biopharma Enters Into Co-Development Agreement With Sanofi Pasteur231
    Sutro Biopharma Enters Into Co-Development Agreement With Celgene242
    Sutro Biopharma Enters Into Collaboration With Pfizer261
  Licensing Agreements271
    EMD Serono Enters into Licensing Agreement with Sutro Biopharma272
    EnWave Enters into License Agreement with Sutro Biopharma for powderREV Technology291
    Sutro Biopharma Enters Into Licensing Agreement With Scripps Research Institute For Click Chemistry301
Sutro Biopharma, Inc. - Key Competitors311
Key Employees321
Locations And Subsidiaries331
  Head Office331
  Other Locations &Subsidiaries331
Appendix341
  Methodology341
  About GlobalData341
  Contact Us341
  Disclaimer341

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Sutro Biopharma, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Sutro-Biopharma-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-6913>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Sutro Biopharma, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Sutro-Biopharma-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-6913>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research